Vanc led its TSX-v category in trading volume for 2015, which was mostly pre-revenue.  The rate in 2016 should start to catch up when more meaningful revenue starts getting reported soon.
   
 | VANC Pharmaceuticals Inc. |  NPH | 119% | 191% | 241,384,075 | Clean Technology & Life Sciences | BC |    |   |  | Tribute Pharmaceuticals Canada Inc. |  TRX | 129% | 176% | 140,738,060 | Clean Technology & Life Sciences | ON |  |   |  | Canopy Growth Corporation* |  CGC | 44% | 340% | 93,764,501 | Clean Technology & Life Sciences | ON |    |   |  | Sernova Corp. |  SVA | 100% | 118% | 36,704,930 | Clean Technology & Life Sciences | BC |  |   |  | OrganiGram Holdings Inc. |  OGI | 49% | 88% | 55,878,735 | Clean Technology & Life Sciences | NB |    |   |  | Medicure Inc. |  MPH | 116% | 155% | 8,038,156 | Clean Technology & Life Sciences | MB |  |   |  | Aphria Inc.* |  APH | 22% | 64% | 31,221,455 | Clean Technology & Life Sciences | ON |    |   |  | BIOREM Inc.* |  BRM | 127% | 165% | 7,012,755 | Clean Technology & Life Sciences | ON |    |   |  | bioMmune Technologies Inc.* |  IMU | 60% | 120% | 8,444,124 | Clean Technology & Life Sciences | BC |  |   |  | Clearford Water Systems Inc. |  CLI | 33% | 53% | 9,301,634 | Clean Technology & Life Sciences | ON |    |   |  
  |